Boothbay Fund Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-12,800
Closed -$86K – 2262
2025
Q4
$86K Buy
+12,800
New +$96K ﹤0.01% 1762
2025
Q1
– Sell
-17,721
Closed -$163K – 1575
2024
Q4
$163K Buy
17,721
+5,785
+48% +$54.1K ﹤0.01% 1228
2024
Q3
$116K Buy
+11,936
New +$125K ﹤0.01% 1444
2024
Q2
– Sell
-47,648
Closed -$385K – 1689
2024
Q1
$385K Buy
+47,648
New +$337K 0.01% 1109
2019
Q4
– Sell
-10,396
Closed -$498K – 909
2019
Q3
$498K Buy
+10,396
New +$542K 0.05% 461

Other funds holding INGN

Boothbay Fund Management's INGN Position: Q1 2026 in Review

Boothbay Fund Management sold out of Inogen (INGN) in Q1 2026, closing a stake of 12,800 shares — an estimated $86K sold.

Boothbay Fund Management first reported a position in INGN in Q3 2019 and held it in 5 quarters. The position peaked at $498K in Q3 2019. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • Boothbay Fund Management reported no remaining Inogen position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 12,800 Inogen shares in Q1 2026, an estimated $86K.
  • Boothbay Fund Management first reported a position in Inogen in Q3 2019 and held it in 5 quarters.
  • Boothbay Fund Management's Inogen position peaked at $498K in Q3 2019.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.